Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2
Clinical trial NCT01763905 · COMPLETED
Trial details
- NCT number
- NCT01763905
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-24
- Primary completion
- 2013-11-19
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.